Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“Canopy Growth” or “the Company”) today announced the voting results from its annual general and special meeting of shareholders held earlier today (the “Meeting”).

A total of 260,647,934 common shares of the Company, representing 70.22% of the issued and outstanding common shares of the Company, were voted in connection with the Meeting by shareholders and proxy holders.

All of the matters put forward before the Company’s shareholders for consideration and approval, as set out in the Company’s proxy statement dated August 6, 2020 (the ” Proxy Statement “), were approved by the requisite majority of votes cast at the Meeting. The results are set out below.

Each of the directors listed as a nominee in the Proxy Statement was elected as a director of the Company at the Meeting. The detailed results of the vote for the election of directors held at the Meeting are set out below:

Name of Nominee Votes cast FOR % votes cast
FOR
Votes W
ITHHELD
% votes
WITHHELD
Judy A. Schmeling 171,131,011 99.13% 1,498,776 0.87%
David Klein 170,997,118 99.05% 1,632,669 0.95%
Robert L. Hanson 170,690,385 98.88% 1,939,402 1.12%
David Lazzarato 171,335,711 99.25% 1,294,076 0.75%
William Newlands 167,146,432 96.82% 5,483,355 3.18%
Jim Sabia 170,995,471 99.05% 1,634,316 0.95%
Theresa Yanofsky 171,415,485 99.30% 1,214,302 0.70%

At the Meeting, Canopy Growth shareholders approved the appointment of KPMG LLP as the Company’s auditors for the 2021 fiscal year and authorized the board of directors to fix its remuneration. In addition, Canopy Growth shareholders approved certain amendments to the Company’s Amended and Restated Omnibus Incentive Plan (the ” OIP “) and all unallocated awards issuable under the OIP as well as certain amendments to the Company’s 2017 Employee Stock Purchase Plan, as further described in the Proxy Statement.

Canopy Growth shareholders also approved advisory (non-binding) resolutions on the compensation of the Company’s named executive officers and to hold “say-on-pay” votes each year.

A report of voting results on all resolutions voted on at the Meeting will be available on both the Company’s EDGAR and SEDAR pages at www.sec.gov/edgar and www.sedar.com , respectively.

About Canopy Growth Corporation
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.

Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.

From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen , breeding legends DNA Genetics and Green House Seeds, as well as lifestyle guru Martha Stewart and Fortune 500 alcohol leader Constellation Brands, to name but a few. For more information visit www.canopygrowth.com

Cision View original content to download multimedia: http://www.prnewswire.com/news-releases/canopy-growth-announces-results-of-annual-general-and-special-meeting-of-shareholders-301135048.html

SOURCE Canopy Growth Corporation

News Provided by PR Newswire via QuoteMedia

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less